Jessica is a project toxicologist in preclinical safety at Blueprint Medicines Corporation in Cambridge, MA. She represents her department on multidisciplinary project teams spanning discovery, development, and post-marketing phases and is responsible for toxicology strategy and risk assessment, study design and oversight of its execution, authoring of toxicology sections of global regulatory submissions, responding to health authority questions, and all other toxicology needs that arise. Previously, Jessica held positions at Takeda, Allergan and Sage Therapeutics with increasing responsibilities. Jessica received her PhD in Pharmacology and Toxicology from the University of Arizona in 2017. Within SOT, Jessica has held leadership roles within the Graduate Student Leadership Committee, Women in Toxicology Special Interest Group, Regulatory and Safety Evaluation Specialty Section, Mentoring Task Force, and Education and Career Development Committee. In addition, Jessica is an active member within the American College of Toxicology.